Xellia Pharmaceuticals

Pharmaceuticals, Copenhagen, Capital Region, Denmark, 1001-5000 Employees

xellia.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 45********

Who is XELLIA PHARMACEUTICALS

Xellia Pharmaceuticals ('Xellia') is a global leader in providing critical care therapies and anti-infective treatments against serious and often life-threatening infections; ranging from...

Read More

map
  • Copenhagen, Capital Region, Denmark Headquarters: Copenhagen, Capital Region, Denmark
  • 1903 Date Founded: 1903
  • 1001-5000 Employees: 1001-5000
  • dollar-icon Revenue: $250 Million to $500 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 541715 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from XELLIA PHARMACEUTICALS

Xellia Pharmaceuticals Org Chart and Mapping

Employees

Mike Sherrod

Industrial Electrician

Kelsy Kurcsak

Environmental Health & Safety Specialist II

Valerie Minica

Sterile Operations Supervisor- Rtu Manufacturing

Toma Randjelovic

Manufacturing Science and Technology Manager

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Xellia Pharmaceuticals

Answer: Xellia Pharmaceuticals's headquarters are located at Copenhagen, Capital Region, Denmark,

Answer: Xellia Pharmaceuticals's phone number is 45********

Answer: Xellia Pharmaceuticals's official website is https://xellia.com

Answer: Xellia Pharmaceuticals's revenue is $250 Million to $500 Million

Answer: Xellia Pharmaceuticals's SIC: 2834

Answer: Xellia Pharmaceuticals's NAICS: 541715

Answer: Xellia Pharmaceuticals has 1001-5000 employees

Answer: Xellia Pharmaceuticals is in Pharmaceuticals

Answer: Xellia Pharmaceuticals contact info: Phone number: 45******** Website: https://xellia.com

Answer: Xellia Pharmaceuticals ('Xellia') is a global leader in providing critical care therapies and anti-infective treatments against serious and often life-threatening infections; ranging from Active Pharmaceutical Ingredients (APIs) to drug products (FDFs), and from generics to specialty pharmaceuticals. Customers depend on us for reliable supply and consistent quality, and to exemplify responsible manufacturing, production, and research and development that promote long-term sustainability. Headquartered in Copenhagen, Denmark and owned by Novo Holdings A/S, Xellia Pharmaceuticals has more than 1800 employees globally. From state-of-the-art manufacturing sites in the U.S., China, Denmark and Hungary to R&D sites in Norway and Croatia and commercial operations across Europe, Asia, the Middle East and North America; Xellia Pharmaceuticals strong market position is built on more than 120 years of pharmaceutical industry experience. With the patient in focus, Xellia is building a pipeline of value-added critical care therapies which aim to enhance patient care by providing convenience and ease of use for healthcare professionals.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access